Did you know 68% of major U.S. hospitals now use genetic testing to personalize treatments? The pharmacogenomics sector is booming, with the global market expected to hit $10.68 billion by 2033. This explosive growth has caught the attention of investors seeking cutting-edge opportunities. Let's discuss Venture Capital Trends in Pharmacogenomics.
Leading companies like Thermo Fisher and Abbott Labs are driving innovation. They're developing advanced testing panels and platforms that analyze genetic data. These tools help doctors prescribe the right drugs at the right doses.
Artificial intelligence is transforming drug development too. By analyzing massive genetic datasets, AI helps researchers identify promising treatments faster. Regulatory changes also play a role, with 42 countries now supporting genetic testing guidelines.
The healthcare industry is shifting toward personalized medicine. This creates exciting prospects for business...
_____
If you are a member of our Association, please log in below to continue reading our exclusive content.
Not a member yet? Discover the benefits of joining our network and gain access to exclusive content like this for only $29.95 per month. Learn More and Sign Up
